On the deal, Homburger and Wilmer Cutler Pickering Hale and Dorr advised Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc. successfully completed its issuance of its...
Thermo Fisher Scientific’s CHF1.425 Billion Bond Issuance
State Street Corporation’s $2.75 Billion Notes Offering
Wilmer Cutler Pickering Hale and Dorr advised State Street Corporation on the offering, and Cravath, Swaine & Moore advised the underwriters. State Street Corporation closed its...
Mountaingate Capital’s Acquisition of North & Warren and Interluxe Group
Wilmer Cutler Pickering Hale and Dorr represented Mountaingate Capital in the transaction. Mountaingate Capital (“Mountaingate”), a private equity firm specializing in partnering with founders and entrepreneurial...
Thermo Fisher’s $4.1 Billion Acquisition of Purification and Filtration Business from Solventum
Wilmer Cutler Pickering Hale and Dorr advised Thermo Fisher Scientific Inc. on the transaction, and Cleary Gottlieb Steen & Hamilton advised Solventum. Solventum announced the definitive...
Asbury Automotive Group’s $1.34 Billion Acquisition of Herb Chambers Companies
Jones Day represented Asbury Automotive Group, Inc. in the transaction, and Wilmer Cutler Pickering Hale and Dorr represented The Herb Chambers Companies. Asbury Automotive Group, Inc....
State Street Corporation’s $750 Million Preferred Stock Offering
Wilmer Cutler Pickering Hale and Dorr represented State Street Corporation on the offering, and Cravath, Swaine & Moore represented the underwriters. State Street Corporation (NYSE: STT)...
Disc Medicine’s $259.3 Million Follow-on Offering
Goodwin Procter advised Disc Medicine, while Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the offering. Disc Medicine (NASDAQ: IRON) announced its upsized underwritten...
Nordstrom Family and Liverpool’s $6.25 Billion Acquisition of Nordstrom
Wilmer Cutler Pickering Hale and Dorr LLP, Lane Powell PC and Davis Wright Tremaine LLP are acting as legal counsel to the Nordstrom Family; Simpson Thacher...
Trevi Therapeutics’ $50 Million Common Stock Offering
Wilmer Cutler Pickering Hale and Dorr represented Trevi Therapeutics, Inc. in the offering, and Covington & Burling represented the underwriters. Trevi Therapeutics, Inc. (Nasdaq: TRVI), a...
Viridian Therapeutics’ $258.8 Million Follow-on Public Offering
Ropes & Gray represented Viridian Therapeutics, Inc. in the offering, and Wilmer Cutler Pickering Hale and Dorr represented the underwriters. Viridian Therapeutics, Inc. (Nasdaq: VRDN), a...
Choice Hotels’ $600 Million Senior Notes Offering
Wilmer Cutler Pickering Hale and Dorr represented Choice Hotels International, Inc. in the offering, and Cahill Gordon & Reindel represented the underwriters. Choice Hotels International, Inc....
Orna Therapeutics’ Acquisition of ReNAgade Therapeutics
Wilmer Cutler Pickering Hale and Dorr advised Orna Therapeutics on the transaction. Orna Therapeutics, a biotechnology company, announced its acquisition of ReNAgade Therapeutics, a pioneer in...